Cognitive Research Enterprises, Inc.
Records under this name other than the patents Cognitive Research Enterprises, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.
Showing 1 to 6 of 6 · Back to Cognitive Research Enterprises, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,962,357 | Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases Formerly held Lapsed on the fee record Ended May 8, 2026 · USPTO record | Lapsed on the fee record | Ended May 8, 2026 | USPTO record |
| US 9,066,923 | Methods for Alzheimer's disease treatment and cognitive enhancement Term ended Term ended Aug 10, 2023 · USPTO record | Term ended | Term ended Aug 10, 2023 | USPTO record |
| US 9,345,685 | Methods for Alzheimer's Disease treatment and cognitive enhancement Term ended Term ended Jul 27, 2023 · USPTO record | Term ended | Term ended Jul 27, 2023 | USPTO record |
| US 6,825,229 | Methods for Alzheimer's Disease treatment and cognitive enhancement Term ended Term ended Jun 13, 2022 · USPTO record | Term ended | Term ended Jun 13, 2022 | USPTO record |
| US 9,446,020 | Methods for Alzheimer'S disease treatment and cognitive enhancement Term ended Ended no later than Jun 13, 2022 · USPTO record | Term ended | Ended no later than Jun 13, 2022 | USPTO record |
| US 9,539,235 | Methods for Alzheimer's disease treatment and cognitive enhancement Term ended Ended no later than Jun 13, 2022 · USPTO record | Term ended | Ended no later than Jun 13, 2022 | USPTO record |